|
AU2004264341A1
|
|
Coupling syringe system and methods for obtaining a mixed composition
|
|
DK200400752A
|
|
Formation of implants in situ - by injection of polymer soln. or liq. prepolymer
|
|
WO2004081196A2
|
|
Formulations for cell- schedule dependent anticancer agents
|
|
US2003195489A1
|
|
Coupling syringe system and methods for obtaining a mixed composition
|
|
AU2003226353A1
|
|
Process for loading a drug delivery device
|
|
AU2600002A
|
|
Injectable sustained release delivery system with loperamide
|
|
US2001042317A1
|
|
Process and delivery container for lyophilizing active agent
|
|
AU4949701A
|
|
Stoppering method to maintain sterility
|
|
WO0143722A2
|
|
Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
|
|
US6565874B1
|
|
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
USRE37950E
|
|
Biogradable in-situ forming implants and methods of producing the same
|
|
US6355657B1
|
|
System for percutaneous delivery of opioid analgesics
|
|
US6461631B1
|
|
Biodegradable polymer composition
|
|
KR100263443B1
|
|
Biodegradable implant precursor
|
|
US6143314A
|
|
Controlled release liquid delivery compositions with low initial drug burst
|
|
US6261583B1
|
|
Moldable solid delivery system
|
|
US6245345B1
|
|
Filamentous porous films and methods for producing the same
|
|
US5962006A
|
|
Polymer formulation for prevention of surgical adhesions
|
|
AU4652596A
|
|
Liquid polymer delivery system
|
|
US5736152A
|
|
Non-polymeric sustained release delivery system
|
